63 participants
A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-11-18
- Start Date:
- 2022-12-10
- Completion:
- 2024-12-10
Conditions
- HER2-positive Recurrent/Metastatic Breast Cancer
Interventions
- DRUG
No Results Yet